Multiple COVID-19 Vaccines in Development: CNBC

Researchers around the globe are in a race to find a vaccine and treatments for COVID-19 with more than 300,000 confirmed cases reported worldwide. The World Health Organization describes an accelerated process after China shared the genetic sequence: “at least 20 different coronavirus vaccines with some already in clinical trials in record time – just 60 days after sequencing the gene,” reports CNBC. Clinical trials and regulatory safety approvals could take 18 months, essential to detect potential side effects and maintain public trust. The article warns of logistical, financial and ethical hurdles, as global experts suggest doses could be required for half the world’s population. The WHO suggests that global protection requires the vaccine to be affordable and available to all. – YaleGlobal

Multiple COVID-19 Vaccines in Development: CNBC

World Health Organization insists full global protection against COVID-19 requires a vaccine available for all – as many as 20 are in research and development
Noah Higgins-Dunn and Emma Newburger
Monday, March 23, 2020

Read the article from CNBC about efforts to develop a vaccine to prevent COVID-19.

Noah Higgins-Dunn is a digital associate for CNBC. He graduated with his degree in journalism from the University of Missouri with an emphasis in business and economics reporting. Emma Newburger covers climate change and breaking news for CNBC.com.

Development of New Vaccines •	Exploratory stage •	Pre-clinical stage •	Clinical development o	Phase I, small groups of people receive the trial vaccine o	Phase II, the clinical study is expanded and vaccine is given to people who have characteristics (such as age and physical health) similar to those for whom the new vaccine is intended o	Phase III, the vaccine is given to thousands of people and tested for efficacy and safety o	Phase IV formal, ongoing studies after approval and licensing •	Regulatory review and approval •	Manufacturing o	Phase IV formal, ongoing studies after approval and licensing •	Quality control

(Source: US Centers for Disease Control and Prevention)

Also read “Principles and Considerations for Adding a Vaccine to a National Immunization Program” from the World Health Organizaton.

© 2020 CNBC LLC. All Rights Reserved.

Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.